Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives
Carlo Di Bonaventura, Angelo Labate, Marta Maschio, et al.
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 16, pp. 1751-1764
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies
Xi Wang, Yuanxun Wang, Xuemin Li, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1650-1671
Open Access | Times Cited: 104
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)
Antonietta Coppola, Alessia Zarabla, Andrea Maialetti, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 43
The role of AMPA receptors and their antagonists in status epilepticus
Antonio Leo, Giada Giovannini, Emilio Russo, et al.
Epilepsia (2018) Vol. 59, Iss. 6, pp. 1098-1108
Open Access | Times Cited: 41
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy
Roberta Celli, Francesco Fornai
Current Neuropharmacology (2020) Vol. 19, Iss. 6, pp. 747-765
Open Access | Times Cited: 33
Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission
Ashwin Kumaria, Keyoumars Ashkan
Brain Research (2023) Vol. 1818, pp. 148515-148515
Closed Access | Times Cited: 12
The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents
Ming-Chi Lai, Ray-Chang Tzeng, Chin‐Wei Huang, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 638-638
Open Access | Times Cited: 27
Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study
Wendyl D’Souza, Taoufik Alsaadi, Javier Montoya, et al.
Seizure (2022) Vol. 100, pp. 56-66
Open Access | Times Cited: 15
Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre
Alessandra Morano, Jinane Fattouch, Mariarita Albini, et al.
Journal of the Neurological Sciences (2018) Vol. 390, pp. 67-74
Closed Access | Times Cited: 27
The impact of perampanel and targeting AMPA transmission on anti-seizure drug discovery
Simona Lattanzi, Pasquale Striano
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 3, pp. 195-197
Open Access | Times Cited: 23
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy
Angelo Pascarella, Luigi Francesco Iannone, Giancarlo Di Gennaro, et al.
Journal of the Neurological Sciences (2020) Vol. 415, pp. 116903-116903
Closed Access | Times Cited: 21
Modulation of AMPA Receptor Gating by the Anticonvulsant Drug, Perampanel
Christine Yuan, Edward Y. Shi, Jayasri Srinivasan, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 10, Iss. 3, pp. 237-242
Open Access | Times Cited: 22
Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, et al.
Molecular Pharmacology (2019) Vol. 96, Iss. 6, pp. 835-850
Open Access | Times Cited: 22
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis
Laura Bellingacci, Martina Tallarico, Andrea Mancini, et al.
Neuropharmacology (2022) Vol. 225, pp. 109373-109373
Closed Access | Times Cited: 12
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study
James W. Wheless, Robert Wechsler, Patricia Penovich, et al.
Epilepsy & Behavior (2023) Vol. 147, pp. 109369-109369
Open Access | Times Cited: 7
Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions
Hamid Mollazadeh, Elmira Mohtashami, Seyed Hadi Mousavi, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 37, pp. 4777-4788
Closed Access | Times Cited: 16
Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
Ivan Rektor, Gregory L. Krauss, Yushi Inoue, et al.
Epilepsia (2020) Vol. 61, Iss. 7, pp. 1491-1502
Open Access | Times Cited: 16
Effect and tolerability of perampanel in patients with drug-resistant epilepsy
Ida Marie Bakke Lossius, Torleiv Svendsen, Hild Flatmark Sødal, et al.
Epilepsy & Behavior (2021) Vol. 119, pp. 107965-107965
Open Access | Times Cited: 14
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System
Carmen De, Claudia Cristiano, Carmen Avagliano, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 13
Long-term efficacy and safety of perampanel as a first add-on therapy in patients with focal epilepsy: Three-year extension study
Kayeong Im, Sang‐Ahm Lee, Ji Hyun Kim, et al.
Epilepsy & Behavior (2021) Vol. 125, pp. 108407-108407
Open Access | Times Cited: 13
Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience
Anna Mammì, Edoardo Ferlazzo, Sara Gasparini, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators
Mohammad Qneibi, Mohammad Hawash, Nidal Jaradat, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5264-5275
Open Access | Times Cited: 10
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy
Pim B. van der Meer, Linda Dirven, Marta Fiocco, et al.
Neurology (2023) Vol. 100, Iss. 14
Open Access | Times Cited: 5
Thiazole Derivatives as Modulators of GluA2 AMPA Receptors: Potent Allosteric Effects and Neuroprotective Potential
Mohammed Hawash
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1694-1694
Open Access | Times Cited: 5
Creutzfeldt-Jakob Disease Presenting as Expressive Aphasia and Nonconvulsive Status Epilepticus
Hafiz Mahboob, Kazi H. Kaokaf, Jeremy M. Gonda
Case Reports in Critical Care (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top